National and Kapodistrian University of Athens
Διερεύνηση των ρυθμιστικών γονιδίων της αιμοποίησης στη λευχαιμογένεση της παιδικής ηλικίας
Abstract
dc:descriptionThe most frequent targets of genetic alterations in human leukemias are transcription factor genes with essential functions in normal blood cell development. It has already been demonstrated that a subset of genes expressed in normal hematopoietic stem cells (HSCs) are highly reactivated in leukemic stem cells (LSCs), thus indicating that the leukemic transformation of progenitor cells is associated with the ectopic reactivation of genes that are responsible for normal cell renewal. In the present study we have investigated the expression levels of four such genes, namely HOXA9, MEIS1, AML1 and IRF4, which are potent regulators of normal hematopoiesis and thus possibly implicated in the development of childhood leukemia. High expression levels of all four genes, albeit in different percentages, were detected in a broad range of leukemic subtypes, both immunophenotypically and cytogenetically. Aberrant activation of HOXA9, MEIS1 and AML1 was observed in cytogenetic subgroups other than the ones known to be associated with the expression of these genes, thus suggesting an implication of the genes in a broader range of leukemic subtypes than previously thought. Moreover, statistically significant correlations were observed between abnormally high gene expression patterns and relapse, overall survival, and minimal residual disease. More specifically, aberrant expression patterns of HOXA9 and MEIS1 could be used as markers of relapse and dismal overall survival, respectively, while IRF4 overexpression could become an important predictor of good prognosis and response to therapy. Collectively, our results have shown that three of the four genes studied could be further investigated for their potential to be used as additional prognostic markers of the disease at diagnosis. The identification of abnormal gene expression patterns can provide important information on the role that certain genes play in the development of childhood acute leukemia, and help us gain a better understanding of the steps that lead to leukemia. This may in turn reveal new molecular targets for the development of novel, patient-tailored therapeutic approaches, based on the molecular profile at diagnosis. Only through the identification of such molecular targets can we hope for successful treatment in cases of unfavorable prognosis or resistant disease.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2016
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Adamaki, Maria
- Αδαμάκη, Μαρία
Subjects
dc:subject × 14Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/39643